Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
American Society of Hematology (ASH 2026)12 - 15 December 2026
A clinical drug–drug interaction study evaluating the effect of etavopivat on sensitive substrates of CYP3A4 and key drug transporters supporting coadministration with common medications used in sickle cell disease and thalassemia
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.